American Bio Medica Corp (ABMC) SEC Filing 8-K Material Event for the period ending Thursday, June 21, 2018

American Bio Medica Corp

CIK: 896747 Ticker: ABMC

View differences made from one to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.


Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ABMC
CIK: 896747
Form Type: 8-K Corporate News
Accession Number: 0001654954-18-006977
Submitted to the SEC: Tue Jun 26 2018 3:24:05 PM EST
Accepted by the SEC: Tue Jun 26 2018
Period: Thursday, June 21, 2018
Industry: Pharmaceutical Preparations
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: